Correlation between Treatment Outcomes and Serum Vitamin D Levels As Well As Infliximab Trough Concentration among Chinese Patients with Crohn’s Disease

Table 5

The influence of infliximab trough concentration on clinical outcomes at the week 14 and week 38 treatment in Crohn’s disease patients.

Time point	Outcomes	IFX-TC
		Insufficiency	Efficiency	Sufficiency
Week 14	Biochemical remission	17/24 (70.83)	17/20 (85)	9/9 (100)	-1.949
	Clinical remission	18/32 (56.25)	19/24 (79.17)	8/10 (80)	-1.914
Week 38	Biochemical remission	11/16 (68.75)	15/19 (78.95)	6/8 (75)	-0.496	0.342
	Clinical remission	17/20 (85)	17/19 (89.47)	7/7 (100)	-0.999	0.245
	Endoscopic remission	16/22 (72.73)	13/18 (72.22)	9/9 (100)	-1.258	0.121
	Endoscopic response	12/22 (54.55)	13/18 (72.22)	9/9 (100)	-2.406

Abbreviations: TC: trough concentration; IFX: infliximab; CD: Crohn’s disease. .